(Q48671403)

English

Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride

scientific article published on August 19, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/1720879

Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride (English)

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

R. E. See

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1720879

8 November 2022

language of work or name

0 references

publication date

1 August 1991

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/1720879

19 August 1991

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1720879

8 November 2022

number of pages

4

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:030439409190477B?httpAccept=text/xml

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

https://api.elsevier.com/content/article/PII:030439409190477B?httpAccept=text/plain

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Neuroscience Letters

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/1720879

129

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/1720879

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/1720879

265-268

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/1720879

Dopamine turnover in the corpus striatum and the lumbic system after treatment with neuroleptic and anti-acetylcholine drugs.

1

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Homovanillic acid in caudate and pre-frontal cortex following acute and chronic neuroleptic administration

2

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

4

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Tolerance to haloperidol-induced increases in dopamine metabolites: fact or artifact?

5

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis

6

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.

7

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis

8

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Haloperidol: Effect of Long-Term Treatment on Rat Striatal Dopamine Synthesis and Turnover

9

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake.

10

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.

11

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats

12

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration

13

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Acute and subacute effects of neuroleptics on dopamine synthesis and release in the rat striatum

14

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats.

15

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Recording oral activity in rats reveals a long-lasting subsensitivity to haloperidol as a function of duration of previous haloperidol treatment

16

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.

17

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

18

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis

19

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Repeated haloperidol administration changes basal release of striatal dopamine and subsequent response to haloperidol challenge.

20

1 reference

10.1016/0304-3940(91)90477-B

https://api.crossref.org/works/10.1016/0304-3940(91)90477-B

8 November 2022

Identifiers

10.1016/0304-3940(91)90477-B

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/1720879

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/1720879

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48671403&oldid=1774678603"